Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-10 Sale | 2022-03-14 4:56 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 12,823 | $15.55 | $199,335 | 201,883 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 4:18 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,388 | $12.66 | $17,568 | 172,359 (Direct) | View |
| 2021-06-02 Sale | 2021-06-02 9:43 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 15,037 | $21.64 | $325,383 | 169,872 (Direct) | View |
| 2021-04-22 Sale | 2021-04-26 9:45 pm | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 87,339 | $26.45 | $2,310,106 | 151,720 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-01 Option Award | 2022-03-03 6:08 pm | N/A 2032-02-29 | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 199,500 | $0 | 481,451 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 6:08 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 42,347 | $0 | 481,451 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 4:46 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 3,875 | $0 | 173,747 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-02 9:43 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 33,189 | $0 | 169,872 (Direct) | View |
| 2021-03-02 Tax Withholding | 2021-03-03 8:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 2,844 | $23.25 | 464,651 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:36 pm | N/A 2031-02-28 | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 149,200 | $0 | 464,651 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 8:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 34,047 | $0 | 464,651 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 8:36 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 7,333 | $24.06 | 464,651 (Direct) | View |
| 2021-02-01 Tax Withholding | 2021-02-03 5:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,308 | $21.35 | 219,064 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 5:29 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 3,875 | $0 | 219,064 (Direct) | View |
| 2020-12-15 Tax Withholding | 2020-12-17 5:07 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 370 | $4.59 | 212,622 (Direct) | View |
| 2020-12-15 Exercise | 2020-12-17 5:07 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,300 | $0 | 212,622 (Direct) | View |
| 2020-06-01 Tax Withholding | 2020-06-03 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 9,451 | $1.32 | 244,881 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:45 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 33,188 | $0 | 244,881 (Direct) | View |
| 2020-03-02 Tax Withholding | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 7,162 | $1.26 | 480,931 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 25,750 | $0 | 480,931 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:30 pm | N/A 2030-03-01 | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 215,726 | $0 | 480,931 (Direct) | View |
| 2020-02-03 Tax Withholding | 2020-02-04 7:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,308 | $1.28 | 177,117 (Direct) | View |
| 2020-02-03 Exercise | 2020-02-04 7:12 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 3,875 | $0 | 177,117 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 356 | $1.81 | 166,800 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 4:18 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,250 | $0 | 166,800 (Direct) | View |
| 2019-12-16 Tax Withholding | 2019-12-18 11:02 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 370 | $1.8 | 167,206 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 11:02 am | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer | 1,300 | $0 | 167,206 (Direct) | View |